Peres, T., Aeppli, S., Fischer, S., Hundsberger, T., & Rothermundt, C. (2025). First Single-Centre Experience with the Novel HIF-α Inhibitor Belzutifan in Switzerland. Current oncology (Toronto), 32(2), 64. https://doi.org/10.3390/curroncol32020064
Citace podle Chicago (17th ed.)Peres, Tobias, Stefanie Aeppli, Stefanie Fischer, Thomas Hundsberger, a Christian Rothermundt. "First Single-Centre Experience with the Novel HIF-α Inhibitor Belzutifan in Switzerland." Current Oncology (Toronto) 32, no. 2 (2025): 64. https://doi.org/10.3390/curroncol32020064.
Citace podle MLA (9th ed.)Peres, Tobias, et al. "First Single-Centre Experience with the Novel HIF-α Inhibitor Belzutifan in Switzerland." Current Oncology (Toronto), vol. 32, no. 2, 2025, p. 64, https://doi.org/10.3390/curroncol32020064.